Glaucoma

The Lancet

Volumn 377, Issue 9774, 2011, Pages 1367-1377

  Quigley, Harry A ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOCHROME P450 1B1; EYE DROPS; FLUOROURACIL; MEMANTINE; MITOMYCIN; MYOCILIN; NEUROTROPHIN; PROSTAGLANDIN DERIVATIVE; TUMOR NECROSIS FACTOR; VASCULOTROPIN INHIBITOR; VIRUS VECTOR;

ARGON LASER; ASIA; ASIAN; ASTROCYTE; BLINDNESS; CATARACT; CENTRAL NERVOUS SYSTEM DISEASE; CHINESE; CHRONIC DISEASE; CLOSED ANGLE GLAUCOMA; CONFERENCE PAPER; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; DIGITAL IMAGING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPIPHORA; EUROPE; GENE MUTATION; GENE THERAPY; GENETIC RISK; GLAUCOMA; GLAUCOMA SURGERY; GONIOSCOPY; HUMAN; INDIAN; INTRAOCULAR HEMORRHAGE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; IRIDOTOMY; LEBER CONGENITAL AMAUROSIS; LOW TENSION GLAUCOMA; MALIGNANT GLAUCOMA; MEDICAL PHOTOGRAPHY; NEGRO; NEOVASCULAR GLAUCOMA; NEUROPROTECTION; NONHUMAN; OPEN ANGLE GLAUCOMA; OPHTHALMOSCOPY; OPTIC DISK; OPTIC NERVE ATROPHY; OPTIC NERVE DISEASE; PATHOGENESIS; PERIMETRY; PHOTOPHOBIA; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREVALENCE; PRIMARY GLAUCOMA; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; RETINA GANGLION CELL; RISK FACTOR; SECONDARY GLAUCOMA; SUSTAINED DRUG RELEASE; TONOMETER; TONOMETRY; TRABECULECTOMY; TRABECULOPLASTY; TRABECULOTOMY; VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

EID: 79954621581     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61423-7     Document Type: Conference Paper

References (106)

1. HA Quigley, A Broman The number of persons with glaucoma worldwide in 2010 and 2020 Br J Ophthalmol 90 2006 151 156
2. PJ Foster, R Buhrmann, HA Quigley, GJ Johnson The definition and classification of glaucoma in prevalence surveys Br J Ophthalmol 86 2002 238 242 (Pubitemid 34127552)
3. CF Burgoyne, JC Downs, AJ Bellezza, JK Suh, RT Hart The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage Prog Retin Eye Res 24 2005 39 73 (Pubitemid 39535155)
4. Y Suzuki, A Iwase, M Araie Risk factors for open-angle glaucoma in a Japanese population: the Tajimi study Ophthalmology 113 2006 1613 1617 (Pubitemid 44292321)
5. MC Leske Open-angle glaucoma - an epidemiologic overview Ophthalmic Epidemiol 14 2007 166 172 (Pubitemid 47493715)
6. MR Wilson The myth of "21" J Glaucoma 6 1997 75 77
7. HA Quigley, DS Friedman, NG Congdon Possible mechanisms of primary angle-closure and malignant glaucoma J Glaucoma 12 2003 167 180 (Pubitemid 36427706)
8. MV Boland, L Zhang, AT Broman, HD Jampel, HA Quigley Comparison of optic nerve head topography and visual field in eyes with open angle and angle closure glaucoma Ophthalmology 115 2008 239 245
9. GR Douglas, SM Drance, M Schulzer The visual field and nerve head in angle-closure glaucoma. A comparison of the effects of acute and chronic angle closure Arch Ophthalmol 93 1975 409 411
10. M Sarfarazi, I Stoilov, JB Schenkman Genetics and biochemistry of primary congenital glaucoma Ophthalmol Clin North Am 16 2003 543 554 (Pubitemid 38044989)
11. A Heijl, B Bengtsson, L Hyman, MC Leske Early Manifest Glaucoma Trial Group Natural history of open-angle glaucoma Ophthalmology 116 2009 2271 2276
12. HV Danesh-Meyer, MV Boland, PJ Savino Optic disc morphology in open-angle glaucoma compared with anterior ischemic optic neuropathies Invest Ophthalmol Vis Sci 51 2010 2003 2010
13. JL Kielczewski, ME Pease, HA Quigley The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina Invest Ophthalmol Vis Sci 46 2005 3188 3196 (Pubitemid 44264304)
14. TC Jakobs, RT Libby, Y Ben, SW John, RH Masland Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice J Cell Biol 171 2005 313 325 (Pubitemid 41540023)
15. HA Quigley, EM Addicks Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage Arch Ophthalmol 99 1981 137 143 (Pubitemid 11168786)
16. AT Broman, HA Quigley, SK West Estimating the rate of progressive visual field damage among those with open-angle glaucoma from cross-sectional data Invest Ophthalmol Vis Sci 49 2008 66 76
17. MC Leske, AM Connell, SY Wu Incidence of open-angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group Arch Ophthalmol 119 2001 89 95 (Pubitemid 32096390)
18. BN Mukesh, CA McCarty, JL Rait, HR Taylor Five-year incidence of open-angle glaucoma: the visual impairment project Ophthalmology 109 2002 1047 1051 (Pubitemid 34546909)
19. S Resnikoff, D Pascolini, D Etya'ale Global data on visual impairment in 2002 Bull World Health Organ 82 2004 844 851 (Pubitemid 39573742)
20. RC Wolfs, CC Klaver, RS Ramrattan, CM van Duijn, A Hofman, PT de Jong Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study Arch Ophthalmol 116 1998 1640 1645 (Pubitemid 29001963)
21. JM Teikari Genetic factors in open-angle (simple and capsular) glaucoma. A population-based twin study Acta Ophthalmol (Copenh) 65 1987 715 720 (Pubitemid 18022793)
22. JM Tielsch, A Sommer, J Katz, RM Royall, HA Quigley, J Javitt Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey JAMA 266 1991 369 374
23. L Racette, MR Wilson, LM Zangwill, RN Weinreb, PA Sample Primary open-angle glaucoma in Blacks: a review Surv Ophthalmol 48 2003 295 313 (Pubitemid 36549253)
24. JL Wiggs Genetic etiologies of glaucoma Arch Ophthalmol 125 2007 30 37 (Pubitemid 46072373)
25. G Thorleifsson, KP Magnusson, P Sulem Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma Science 317 2007 1397 1400 (Pubitemid 47417481)
26. K Grødum, A Heijl, B Bengtsson Risk of glaucoma in ocular hypertension with and without pseudoexfoliation Ophthalmology 112 2005 386 390 (Pubitemid 40312488)
27. MV Boland, HA Quigley Risk factors and open-angle glaucoma: concepts and applications J Glaucoma 16 2007 406 418 (Pubitemid 46945541)
28. DS Friedman, MR Wilson, JM Liebmann, RD Rechtner, RN Weinreb An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma Am J Ophthalmol 138 2004 S19 S31
29. JD Brandt Central corneal thickness - tonometry artifact, or something more? Ophthalmology 114 2007 1963 1964 (Pubitemid 350016388)
30. MC Leske, A Heijl, L Hyman Predictors of long-term progression in the Early Manifest Glaucoma Trial Ophthalmology 114 2007 1965 1972 (Pubitemid 350016362)
31. GR Howell, RT Libby, SW John Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection Prog Brain Res 173 2008 303 321
32. IA Sigal, CR Ethier Biomechanics of the optic nerve head Exp Eye Res 88 2009 799 807
33. AL Coleman, S Miglior Risk factors for glaucoma onset and progression Surv Ophthalmol 53 suppl 1 2008 S3 S10
34. MC Leske, A Heijl, M Hussein, B Bengtsson, L Hyman, E Komaroff Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial Arch Ophthalmol 121 2003 48 56 (Pubitemid 36401765)
35. MC Leske Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings Curr Opin Ophthalmol 20 2009 73 78
36. J Caprioli, AL Coleman Blood flow in glaucoma discussion. Blood pressure, perfusion pressure, and glaucoma Am J Ophthalmol 149 2010 704 712
37. B Bengtsson, MC Leske, Z Yang, A Heijl EMGT Group Disc hemorrhages and treatment in the early manifest glaucoma trial Ophthalmology 115 2008 2044 2048
38. FA Medeiros, RN Weinreb, PA Sample Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma Arch Ophthalmol 123 2005 1351 1360 (Pubitemid 41429735)
39. SL Mansberger, GA Cioffi The probability of glaucoma from ocular hypertension determined by ophthalmologists in comparison to a risk calculator J Glaucoma 15 2006 426 431 (Pubitemid 44434997)
40. MV Boland, HA Quigley, HP Lehmann The impact of risk calculation on treatment recommendations made by glaucoma specialists in cases of ocular hypertension J Glaucoma 17 2008 631 638
41. HA Quigley, EM Addicks, WR Green, AE Maumenee Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage Arch Ophthalmol 99 1981 635 649 (Pubitemid 11106037)
42. DR Anderson, A Hendrickson Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve Invest Ophthalmol 13 1974 771 783
43. BP Buckingham, DM Inman, W Lambert Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma J Neurosci 28 2008 2735 2744 (Pubitemid 351398885)
44. KRG Martin, HA Quigley, DJ Zack Gene therapy with brain-derived neurotrophic factor protects retinal ganglion cells in a rat glaucoma model Invest Ophthalmol Vis Sci 44 2003 4357 4365 (Pubitemid 37186270)
45. RT Libby, Y Li, OV Savinova Susceptibility to neurodegeneration in a glaucoma model is modified by Bax gene dosage PLoS Genet 1 2005 17 26
46. W Huang, JB Fileta, A Dobberfuhl Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma Proc Natl Acad Sci USA 102 2005 12242 12247 (Pubitemid 41291159)
47. SJ McKinnon, DM Lehman, NG Tahzib Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model Mol Ther 5 2002 780 787 (Pubitemid 34619071)
48. W Hare, E WoldeMussie, R Lai Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey Surv Ophthalmol 45 suppl 3 2001 S284 S289
49. ML Ko, DN Hu, R Ritch, SC Sharma The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma Invest Ophthalmol Vis Sci 41 2000 2967 2971
50. S Bakalash, GB Shlomo, E Aloni T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure J Mol Med 83 2005 904 916 (Pubitemid 41598691)
51. AH Neufeld, S Das, S Vora A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma J Glaucoma 11 2002 221 225 (Pubitemid 34620098)
52. T Nakazawa, C Nakazawa, A Matsubara Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma J Neurosci 26 2006 12633 12641 (Pubitemid 44904557)
53. LA Levin, HV Danesh-Meyer Lost in translation: bumps in the road between bench and bedside JAMA 303 2010 1533 1534
54. L Guo, TE Salt, V Luong Targeting amyloid-beta in glaucoma treatment Proc Natl Acad Sci USA 104 2007 13444 13449
55. V Parisi, R Restuccia, F Fattapposta, C Mina, MG Bucci, F Pierelli Morphological and functional retinal impairment in Alzheimer's disease patients Clin Neurophysiol 112 2001 1860 1867 (Pubitemid 32831524)
56. E Lütjen-Drecoll Importance of trabecular meshwork changes in the pathogenesis of primary open-angle glaucoma J Glaucoma 9 2000 417 418 (Pubitemid 32429186)
57. YH Kwon, JH Fingert, MH Kuehn, WL Alward Primary open-angle glaucoma N Engl J Med 360 2009 1113 1124
58. LK Buie, CA Rasmussen, EC Porterfield Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys Invest Ophthalmol Vis Sci 51 2010 236 248
59. JW Bainbridge, AJ Smith, SS Barker Effect of gene therapy on visual function in Leber's congenital amaurosis N Engl J Med 358 2008 2231 2239 (Pubitemid 351724452)
60. HA Quigley, CK Park, PA Tracey, IP Pollack Community screening for eye disease by laypersons: the Hoffberger program Am J Ophthalmol 133 2002 386 392 (Pubitemid 34171589)
61. JM Burr, G Mowatt, R Hernandez The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation Health Technol Assess 11 2007 1 190
62. BC Chauhan, MT Nicolela, PH Artes Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma Ophthalmology 116 2009 2110 2118
63. P Sharma, PA Sample, LM Zangwill, JS Schuman Diagnostic tools for glaucoma detection and management Surv Ophthalmol 53 suppl 1 2008 S17 S32
64. A Heijl, B Bengtsson, BC Chauhan A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients Ophthalmology 115 2008 1557 1565
65. BC Chauhan, DF Garway-Heath, FJ Goñi Practical recommendations for measuring rates of visual field change in glaucoma Br J Ophthalmol 92 2008 569 573 (Pubitemid 351497993)
66. S Schmitz-Valckenberg, L Guo, A Maass Real-time in vivo imaging of retinal cell apoptosis after laser exposure Invest Ophthalmol Vis Sci 49 2008 2773 2780
67. EM Barnett, X Zhang, D Maxwell, Q Chang, D Piwnica-Worms Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model Proc Natl Acad Sci USA 106 2009 9391 9396
68. MA Kass, DK Heuer, EJ Higginbotham The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma Arch Ophthalmol 120 2002 701 713 (Pubitemid 34620348)
69. NICE clinical guideline 85 Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension http://www.nice.org.uk/CG85 (accessed June 1, 2010).
70. SM Kymes, MR Plotzke, MA Kass, MV Boland, MO Gordon Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension Arch Ophthalmol 128 2010 613 618
71. Collaborative Normal-Tension Glaucoma Study Group Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures Am J Ophthalmol 126 1998 487 497
72. Glaucoma Laser Trial Research Group The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results Am J Ophthalmol 120 1995 718 731
73. F Ederer, DA Gaasterland, LG Dally The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results Ophthalmology 111 2004 651 664
74. PR Lichter, DC Musch, BW Gillespie Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery Ophthalmology 108 2001 1943 1953 (Pubitemid 33032760)
75. HD Jampel Target pressure in glaucoma therapy J Glaucoma 6 1997 133 138 (Pubitemid 27183198)
76. DS Friedman, HA Quigley, L Gelb Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS) Invest Ophthalmol Vis Sci 48 2007 5052 5057 (Pubitemid 351260915)
77. CO Okeke, HA Quigley, HD Jampel Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients Ophthalmology 116 2009 2286 2293
78. SJ Gedde, JC Schiffman, WJ Feuer Three-year follow-up of the tube versus trabeculectomy study Am J Ophthalmol 148 2009 670 684
79. W Tao, R Wen, MB Goddard Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa Invest Ophthalmol Vis Sci 43 2002 3292 3298
80. JLY Yip, PJ Foster Ethnic differences in primary angle-closure glaucoma Curr Opin Ophthalmol 17 2006 175 180 (Pubitemid 43790814)
81. PJ Foster, GJ Johnson Glaucoma in China: how big is the problem? Br J Ophthalmol 85 2001 1277 1282 (Pubitemid 33016101)
82. PH Alsbirk Primary angle-closure glaucoma: oculometry, epidemiology, and genetics in a high risk population Acta Ophthalmol 54 1976 5 31
83. PJ Foster, FTS Oen, D Machin The prevalence of glaucoma in Chinese residents of Singapore Arch Ophthalmol 118 2000 1105 1111
84. L Dandona, R Dandona, P Mandal Angle-closure glaucoma in an urban population in southern India. The Andhra Pradesh Eye Disease Study Ophthalmology 107 2000 1710 1716
85. L Bonomi, G Marchini, M Marrafa Epidemiology of angle-closure glaucoma. Prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarkt Glaucoma Study Ophthalmology 107 2000 998 1003
86. RR Buhrmann, HA Quigley, Y Barron, SK West, MS Oliva, BBO Mmbaga The prevalence of glaucoma in a rural east African population Invest Ophthalmol Vis Sci 41 2000 40 48 (Pubitemid 30036546)
87. M He, PJ Foster, J Ge Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou Invest Ophthalmol Vis Sci 47 2006 2782 2788 (Pubitemid 351639747)
88. M He, D Wang, Y Zheng Heritability of anterior chamber depth as an intermediate phenotype of angle-closure in Chinese: the Guangzhou Twin Eye Study Invest Ophthalmol Vis Sci 49 2008 81 86
89. R Lavanya, T-Y Wong, DS Friedman Determinants of angle closure in older Singaporeans Arch Ophthalmol 126 2008 686 691 (Pubitemid 351679565)
90. HA Quigley, DM Silver, DS Friedman Iris cross-sectional area decreases with pupil dilation and its dynamic behavior is a risk factor in angle closure J Glaucoma 18 2009 173 179
91. F Aptel, P Denis Optical coherence tomography quantitative analysis of iris volume changes after pharmacologic mydriasis Ophthalmology 117 2010 3 10
92. H Sakai, S Morine-Shinjyo Uveal effusion in primary angle-closure glaucoma Ophthalmology 112 2005 413 419 (Pubitemid 40312492)
93. JT Wilensky, PL Kaufman, D Frohlichstein Follow-up of angle-closure glaucoma suspects Am J Ophthalmol 115 1993 338 346 (Pubitemid 23081075)
94. R Sihota, S Mohan, T Dada, V Gupta, RM Pandey, D Ghate An evaluation of the darkroom prone provocative test in family members of primary angle closure glaucoma patients Eye 21 2007 984 989 (Pubitemid 47062085)
95. JL Yip, WP Nolan, CE Gilbert Prophylactic laser peripheral iridotomy and cataract progression Eye 24 2010 1127 1134
96. MHN Ang, M Baskaran, RS Kumar National survey of ophthalmologists in Singapore for the assessment and management of asymptomatic angle closure J Glaucoma 17 2008 1 4 (Pubitemid 351321467)
97. DS Friedman, PT Chew, G Gazzard Long-term outcomes in fellow eyes after acute primary angle closure in the contralateral eye Ophthalmology 113 2006 1087 1091 (Pubitemid 43947231)
98. CJ Pavlin, FS Foster Plateau iris syndrome: changes in angle opening associated with dark, light, and pilocarpine administration Am J Ophthalmol 128 1999 288 291 (Pubitemid 29413223)
99. DS Lam, CC Tham, JS Lai, DY Leung Current approaches to the management of acute primary angle closure Curr Opin Ophthalmol 18 2007 146 151
100. EP Aponte, N Diehl, BG Mohney Incidence and clinical characteristics of childhood glaucoma: a population-based study Arch Ophthalmol 128 2010 478 482
101. N Weisschuh, C Wolf, B Wissinger, E Gramer A clinical and molecular genetic study of German patients with primary congenital glaucoma Am J Ophthalmol 147 2009 744 753
102. JM Martinez-de-la-Casa, J Garcia-Feijoo, F Saenz-Frances Comparison of rebound tonometer and Goldmann handheld applanation tonometer in congenital glaucoma J Glaucoma 18 2009 49 52
103. M Papadopoulos, PT Khaw Advances in the management of paediatric glaucoma Eye 21 2007 1319 1325 (Pubitemid 47534745)
104. JF Bussires, R Therrien, P Hamel, P Barret, S Prot-Labarthe Retrospective cohort study of 163 pediatric glaucoma patients Can J Ophthalmol 44 2009 323 327
105. MB Horsley, MY Kahook Anti-VEGF therapy for glaucoma Curr Opin Ophthalmol 21 2010 112 117
106. L Bielory Ocular toxicity of systemic asthma and allergy treatments Curr Allergy Asthma Rep 6 2006 299 305 (Pubitemid 44056826)